mTOR Pathway Alterations in Chromophobe Renal Cell Carcinoma (RCC)

被引：0
|
作者：
Albadine, R. [1 ]
Schultz, I. [1 ]
Demarza, A. M. [1 ]
Argani, P. [1 ]
Carducci, M. [1 ]
Pili, R. [1 ]
Netto, G. J. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
771
引用
收藏
页码：174A / 174A
页数：1
相关论文
共 50 条
  • [1] mTOR Pathway Alterations in Chromophobe Renal Cell Carcinoma (RCC)
    Albadine, R.
    Schultz, L.
    Hicks, J.
    Demarzo, A. M.
    Argani, P.
    Carducci, M.
    Pili, R.
    Netto, G. J.
    LABORATORY INVESTIGATION, 2010, 90 : 174A - 174A
  • [2] mTOR pathway alterations in chromophobe renal cell carcinoma: Impact on metastasis development and overall survival
    Maroto, Pablo
    Anguera, Georgia
    Maria Roldan, Jose
    Caleiras, E.
    Santos, M.
    Garcia-Donas, Jesus
    de Velasco, Guillermo
    Lanillos, J.
    Martinez, A. M.
    Calsina, B.
    Leton, R.
    Leandro-Garcia, L. J.
    Monteagudo, M.
    Montero-Conde, Cristina
    Cascon, Alberto
    Robledo, Mercedes
    Rodriguez-Antona, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome
    Roldan-Romero, Juan Maria
    Santos, Maria
    Lanillos, Javier
    Caleiras, Eduardo
    Anguera, Georgia
    Maroto, Pablo
    Garcia-Donas, Jesus
    de Velasco, Guillermo
    Martinez-Montes, Angel Mario
    Calsina, Bruna
    Monteagudo, Maria
    Leton, Rocio
    Leandro-Garcia, Luis Javier
    Montero-Conde, Cristina
    Cascon, Alberto
    Robledo, Mercedes
    Rodriguez-Antona, Cristina
    MODERN PATHOLOGY, 2020, 33 (12) : 2580 - 2590
  • [4] Interphase cytogenetic in metastatic chromophobe renal cell carcinoma (RCC).
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 202 - 203
  • [5] MTOR PATHWAY ACTIVATION IN PRIMARY RENAL CELL CARCINOMA (RCC) AND MATCHED METASTASES
    Kutikov, Alexander
    Egleston, Brian L.
    Morrison, Tasha
    Henske, Elizabeth P.
    Huang, Min
    Al-Saleem, Tahseen
    Uzzo, Robert G.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 500 - 500
  • [6] mTOR pathway in renal cell carcinoma
    Hanna, Sara C.
    Heathcote, Samuel A.
    Kim, William Y.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 283 - 292
  • [7] Genetic alterations of HER genes in chromophobe renal cell carcinoma
    Weng, Wen Hui
    Chen, Ying Tzu
    Yu, Kai Jie
    Chang, Ying Hsu
    Chuang, Cheng Keng
    Pang, See Tong
    ONCOLOGY LETTERS, 2016, 11 (03) : 2111 - 2116
  • [8] Combined mTOR and AKT inhibition in renal cell carcinoma (RCC)
    Holland, W. S.
    Mack, P. C.
    Tepper, C. G.
    Gandara, D. R.
    Lara, P., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of conventional renal cell carcinoma
    Wang, HY
    Mills, SE
    MODERN PATHOLOGY, 2005, 18 : 170A - 170A
  • [10] Investigation of ferroptosis and mTOR signaling in chromophobe renal cell carcinoma (ChRCC).
    Madsen, Katrine N.
    Labaki, Chris
    Saad, Eddy
    Alchoueiry, Michel
    Bi, Kevin
    Hobeika, Charbel
    Bakouny, Ziad
    Priolo, Carmen
    Khabibullin, Damir
    Schindler, Nicholas R.
    Camp, Sabrina Yvonne
    Saliby, Renee Maria
    Heng, Daniel Yick Chin
    Van Allen, Eliezer Mendel
    Shukla, Sachet A.
    Henske, Elizabeth
    Choueiri, Toni K.
    Braun, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
12345